Claire Trant
Co-Founder, Untap Health
Claire’s prior work includes innovation in wastewater technologies, she worked on the forefront of international regulation change and innovation. In this work she led international European licensing agreements for nitrate and phosphate removal technologies into British companies. During the COVID-19 pandemic sewage surveillance was being widely used, but very manual. This drove Claire to start Untap Health. She also has a PhD with Rolls Royce Aerospace, understanding failures in materials of military aerospace engines, and ensuring their success in commercial engines.
Contact
Untap Health
We provide an early warning system, detecting the presence of carriers whether they are 1. Asymptomatic (no symptoms) 2. Pre-symptomatic (up to a week before symptoms appear) 3. Symptomatic Daily monitoring enables the appropriate response to the measured risk
Bio
Claire’s prior work includes innovation in wastewater technologies, she worked on the forefront of international regulation change and innovation. In this work she led international European licensing agreements for nitrate and phosphate removal technologies into British companies. During the COVID-19 pandemic sewage surveillance was being widely used, but very manual. This drove Claire to start Untap Health. She also has a PhD with Rolls Royce Aerospace, understanding failures in materials of military aerospace engines, and ensuring their success in commercial engines.
One sentence pitch
Untap Health detects illnesses before symptoms, using our sewage
Industry/Sector
Sector – HealthTech, Customers – Care Homes and Offices, Geography – UK
Company Investment Stage
£1.6million
Company Location
Elephant and Castle, London, UK
Video
Pitch Deck
Problem
Illnesses are only detected when symptoms emerge. Infectious diseases can be infectious up to a week before symptoms, or never show symptoms at all. Other illnesses progress to later stages before they can be detected. Regularly individually testing every member of the community is cost inefficient, time-wasting and logistical challenge.
Solution
We have a created a patent-pending device that any community can install to monitor their health in real-time, detecting both asymptomatic and pre-symptomatic people before symptoms present. A single device can monitor multiple pathogens, and once installed is fully automated. This device is installed in the outgoing sewage of the building and provides daily updates on the population’s overall health, letting you know what measures to implement and when, if any.
Business Model
B2B monthly subscription model starting from £600 per month. Prices increase with increased number of bio-markers being measured (including COVID-19, influenza and Norovirus), and with increased frequency of measurement (i.e., daily vs. hourly measurements).
Competition
Currently, sewage testing technologies are manual, therefore slow, inefficient and expensive. Examples include Biobot analytics and Kando. Untap’s automated, onsite sewage surveillance provides real-time data, over ten times cheaper than competitors.
Traction
We have raised $2m in total, $500k in grants, and generated $220k revenue. Our team is now ten people. We won UK British Angel Award of Growth Woman Founder in 2023.
Looking For
Investors to understand approporiate milestones we need to achieve for our Q2 2024 fundraise and build a relationship pre-raise